Overall Winner: Qure.ai·70/ 100

Predible Health vs Qure.ai

In-depth comparison — valuation, funding, investors, founders & more

P
Predible Health

🇮🇳 India · Sanjoy Paul

Series AAI HealthcareEst. 2017

Valuation

N/A

Total Funding

$5M

50
Awaira Score50/100

10-50 employees

Full Predible Health Profile →
Winner
Q
Qure.ai

🇮🇳 India · Prashant Warier

Series DAI HealthcareEst. 2016

Valuation

$270M

Total Funding

$157M

70
Awaira Score70/100

250 employees

Full Qure.ai Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Predible Health and Qure.ai compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. Qure.

Qure.ai carries a known valuation of $270M, while Predible Health's valuation has not been publicly disclosed. On the funding side, Qure.ai has raised $157M in total — $152M more than Predible Health's $5M.

Qure.ai has 1 year more market experience, having been founded in 2016 compared to Predible Health's 2017 founding. In terms of growth stage, Predible Health is at Series A while Qure.ai is at Series D — a meaningful difference for investors evaluating risk and upside.

Both companies are headquartered in 🇮🇳 India, competing for the same regional talent and customer base. On Awaira's 0–100 composite score, Qure.ai leads with a score of 70, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricPredible HealthQure.ai
💰Valuation
N/A
$270M
📈Total Funding
$5M
$157MWINS
📅Founded
2017WINS
2016
🚀Stage
Series A
Series D
👥Employees
10-50
250
🌍Country
India
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
50
70WINS

Key Differences

📈

Funding gap: Qure.ai has raised $152M more ($157M vs $5M)

📅

Market experience: Qure.ai has 1 year more (founded 2016 vs 2017)

🚀

Growth stage: Predible Health is at Series A vs Qure.ai at Series D

👥

Team size: Predible Health has 10-50 employees vs Qure.ai's 250

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Qure.ai scores 70/100 vs Predible Health's 50/100

Which Should You Choose?

Use these signals to make the right call

P

Choose Predible Health if…

  • Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation
Q

Choose Qure.ai if…

Top Pick
  • Higher Awaira Score — 70/100 vs 50/100
  • More established by valuation ($270M)
  • Stronger investor backing — raised $157M
  • More market experience — founded in 2016
  • Qure

Funding History

Predible Health raised $5M across 0 rounds. Qure.ai raised $157M across 5 rounds.

Predible Health

No public funding data available.

Qure.ai

Series D

Jan 2021

$81M

Series C

Jan 2020

$50M

Series B

Jan 2018

$20M

Series A

Jan 2017

Lead: Accel Partners

$6M

Seed

Jan 2016

Investor Comparison

No shared investors detected between these two companies.

Unique to Qure.ai

Accel PartnersBessemer Venture PartnersGoogle

Users Also Compare

FAQ — Predible Health vs Qure.ai

Is Predible Health bigger than Qure.ai?
Qure.ai has a disclosed valuation of $270M, while Predible Health's valuation is not publicly available, making a direct size comparison difficult. Qure.ai employs 250 people.
Which company raised more funding — Predible Health or Qure.ai?
Qure.ai has raised more in total funding at $157M, compared to Predible Health's $5M — a gap of $152M. Combined, the two companies have completed 5 known funding rounds.
Which company has a higher Awaira Score?
Qure.ai holds the higher Awaira Score at 70/100, compared to Predible Health's 50/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 20-point gap that reflects meaningful differences in scale or traction.
Who founded Predible Health vs Qure.ai?
Predible Health was founded by Sanjoy Paul in 2017. Qure.ai was founded by Prashant Warier in 2016. Visit each company's profile on Awaira for a full founder biography.
What does Predible Health do vs Qure.ai?
Predible Health: Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. The platform integrates with radiology information systems and PACS to provide AI-assisted second reads and quantitative measurements that reduce reporting time and flag critical findings for urgent review.\n\nThe company raised approximately $5M in Series A funding and has established clinical partnerships with hospital networks and diagnostic imaging centers across India. Predible Health received significant validation through its COVID-19 CT analysis tool, which was deployed during the pandemic to help overwhelmed radiology departments manage surge volumes.\n\nRadiology AI represents one of the most commercially mature segments of medical AI globally, with clear clinical workflows, measurable radiologist productivity benefits, and established reimbursement pathways emerging in developed markets. Predible Health's India-focused deployments position it as a domestic alternative to global radiology AI companies, with the advantage of deep integration knowledge in Indian hospital IT environments. Qure.ai: Qure.ai is an Indian artificial intelligence company founded in 2016 that develops machine learning solutions for diagnostic imaging in healthcare. The company specializes in computer-aided detection and diagnosis systems that analyze medical imaging data including chest X-rays, CT scans, and mammograms to identify abnormalities and assist radiologists in clinical decision-making. Its platform uses deep learning algorithms trained on large datasets to detect conditions such as tuberculosis, COVID-19, lung cancer, and other pathologies. Qure.ai's products are deployed across hospitals and diagnostic centers in India and internationally, serving both institutional healthcare providers and diagnostic chains. The company has secured $157 million in total funding and operates at Series D stage with a valuation of $300 million as of recent rounds. Its technology addresses the shortage of radiologists in developing markets while improving diagnostic accuracy and turnaround times. Qure.ai competes in the medical AI space alongside companies like IBM Watson Health, Zebra Medical Vision, and various regional diagnostic AI providers. The company has demonstrated strong traction in the Indian healthcare market and has expanded its reach to international markets. Its growth trajectory reflects increasing adoption of AI-assisted diagnostic solutions globally and the rising demand for scalable healthcare technologies in resource-constrained settings. Qure.ai focuses specifically on diagnostic imaging AI for markets with radiologist shortages, positioning it distinctly within underserved geographies.
Which company was founded first?
Qure.ai was founded first in 2016, giving it 1 year of additional market experience. Predible Health was founded later in 2017. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Predible Health has approximately 10-50 employees, while Qure.ai has approximately 250. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Predible Health and Qure.ai competitors?
Yes, Predible Health and Qure.ai are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.